Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07354100 · ClinicalTrials.gov registry record · Phase 1
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
A Phase 1 study, sponsored by University of Chicago.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 55
- Enrollment target
NCT07354100 is a Phase 1 study that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 55 participants.
The verdict
NCT07354100, a Phase 1 study, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to see if lactulose can improve the effectiveness of immunotherapy in patients with advanced cancer.
Interventions
- DRUG Lactulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2026-12-15 |
| Est. Completion | 2029-04-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07354100
The ClinicalTrials.gov registry entry for NCT07354100 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lactulose is the first listed.
NCT07354100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07354100 about?
NCT07354100 is a clinical study titled "Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy". The purpose of this study is to see if lactulose can improve the effectiveness of immunotherapy in patients with advanced cancer.
What is the current status of trial NCT07354100?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2026-12-15. Estimated completion is 2029-04-13.
What interventions are being tested in trial NCT07354100?
The interventions under investigation include: Lactulose (DRUG).
Who is sponsoring clinical trial NCT07354100?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.